Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Serenoa repens for benign prostatic hyperplasia.
James Tacklind
, Roderick MacDonald
, Indy Rutks
,
Timothy J. Wilt
Medicine - Veteran's Administration Medical Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Serenoa repens for benign prostatic hyperplasia.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Benign Prostatic Hyperplasia
100%
Serenoa Repens
100%
Placebo
66%
Lower Urinary Tract Symptoms
25%
Symptom Score
25%
No Significant Difference
16%
Urinary Symptoms
16%
Nocturia
16%
Prostate Size
16%
Finasteride
16%
Urologic Symptoms
16%
Urine Flow
16%
Tamsulosin
16%
Randomized Trial
8%
Prostate
8%
Patient Outcomes
8%
Clinical Endpoints
8%
Berries
8%
Urodynamic Study
8%
Urodynamics
8%
Plant Use
8%
Adverse Events
8%
Pharmacologic
8%
Enlargement
8%
MEDLINE
8%
Embase
8%
Nonmalignant
8%
Weighted Mean Difference
8%
Cochrane Library
8%
Risk Ratio
8%
New Trial
8%
Allocation Concealment
8%
Treatment Allocation
8%
Specialized Databases
8%
Palm Plants
8%
Irritative
8%
Saw Palmetto
8%
Phytotherapy
8%
Scale Measurement
8%
Clinical Outcomes
8%
Botanical Names
8%
Dwarf Palm
8%
Patient-centered Interventions
8%
Symptom Measurement
8%
Phytotherapeutics
8%
Sabal Serrulata
8%
Medicine and Dentistry
Prostate Hypertrophy
100%
Serenoa
100%
Placebo
66%
Lower Urinary Tract Symptom
25%
Urodynamics
16%
Urinary System
16%
Micturition
16%
Pilus
16%
Nocturia
16%
Tamsulosin
16%
Side Effect
16%
Systematic Review
8%
Independent Reviewer
8%
Phytotherapy
8%
Dwarfism
8%
Adverse Event
8%
Pharmacology, Toxicology and Pharmaceutical Science
Sabal
100%
Prostate Hypertrophy
100%
Placebo
57%
Lower Urinary Tract Symptom
21%
Tamsulosin
14%
Finasteride
14%
Nocturia
14%
Side Effect
14%
Adverse Event
7%
Phytotherapy
7%
Arecaceae
7%
Dwarfism
7%